期刊文献+

川崎病患儿血降钙素原水平检测临床意义的研究 被引量:3

Detection and clinical significance of level of procalcitonin in chidlren with Kawasaki Disease
下载PDF
导出
摘要 目的观察川崎病患儿血清降钙素原(PCT)水平变化,探讨其在川崎病中的临床意义。方法以2005年1月-2007年10月住院的88例川崎病患儿为研究对象,分为冠脉扩张组(32例)及无冠脉扩张组(56例),采用胶体金免疫结合法测定血清PET水平,并与对照组35例健康儿童比较。结果采用积分法发现川崎病患儿PET水平较对照组增高,其差异有统计学意义(t=11.08,P〈0.01),川崎病患儿PCT阳性率73.9%,对照组PCT阳性率14.2%,差异有显著性(x^2=36.25,P〈0.01)。采用积分法发现川崎病患儿有冠脉扩张组PCT水平与无冠脉扩张组无明显差异(t=0.31,P〉0.05),川崎病患儿有冠脉扩张组PCT阳性率68.7%,无冠脉扩张组PET阳性率76.7%,差异无统计学意义(X^2=0.68,P〉0.05)。结论川崎病患儿血PCT水平明显增高,有无冠状动脉扩张患儿血PET水平变化不大,提示PET在川崎病诊断中可作为一项重要的参考指标,但对于冠状动脉扩张预测尚有待于进一步研究。 Objective To study the changes of level of serum procalcitonin (PCT) in children with Kawasaki disease (KD) and explore the clinical significance of PCT. Methods From Jan 2005 to Feb 2008,88 children suffering from KD and thirty three healthy children were recruited in this study. ,which were devided into eoranary arery dilatation gropu consisted of 32 eases and without coronary artery dilatation group consisted of 56 eases. The concentration of serum PCT of KD patients were detected with gold immunobinding assay amd compared with health children. Results The Levels of PCT in KD group were significantly higher than those of health group ( P 〈 0.01 ). The positive rate of levels of PCT in KD group and control group were 73.9% and 14.2% respectively (P 〈 0.01 ) without showing a statistical difference between the patients with coronary artery dilatation and the patients without coronary artery dilatation (P 〉 0.05 ). Positive rate of levels of PCT were 68.7% in the KD group with coronary artery dilatation and 76.7% in the KD group without coronary artery dilatation ( P 〉 0.05). Conclusion The levels of serum PCT are significantly elevated in patients with KD. There is no significant differenee from the patients with coronary artery dilatation and those without cardiac complications, suggesting that PCT is an important indicator in diagnosis of KD.
出处 《中国热带医学》 CAS 2008年第8期1342-1343,共2页 China Tropical Medicine
关键词 皮肤粘膜淋巴结综合征(川崎病) 降钙素原 儿童 Mucocutaneous lymph node syndrome Procalcitonin Children
  • 相关文献

参考文献10

  • 1胡亚美 江载芳.诸福棠实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1514.
  • 2Falcini F. Kawasaki disease[ J]. Curr Opin Rheumatol, 2006,18( 1 ) : 33 -38.
  • 3Yeyng RS. Pathogenesis and treatment of Kawasaki's disease[ J]. Curr Opin Rheumatol, 2005,17(5) :617 -623.
  • 4汪芸,孙丽萍,刘敏,刘春燕,赵地,马官福,王俐,李尔珍.川崎病患儿血清降钙素原水平变化的意义[J].实用儿科临床杂志,2007,22(9):667-668. 被引量:9
  • 5Okada Y, Minakami H, Tomomasa T, et al. Serum procalcitonin concentrationin patients with Kawasaki disease [ J ]. J Infect, 2004,2 (3) : 199 - 205.
  • 6Scire CA, Caporali R, Perotti C, et al. Plasma procalcitonin in rheumatic diseases[ J]. Reumatismo, 2003,55(2) :113 - 118.
  • 7Bartosz K, Agnieszka M J, Andrzej P. High serum procalcitonin concentration in Kawasaki disease[ J]. Med Sci Monit, 1998, 4(6) :1072 - 1074.
  • 8Shulman ST, Rowley AH. Advances in Kawasaki disease[J]. Eur J Pediatr,2004 ,163 :285 - 291.
  • 9Whang KT, Vath SD, Becket KL, et al. Procalcitonin and proin -flammatory cytokine interactions in sepsis[ J ]. Shock, 2000, 14( 1 ) :73 - 78.
  • 10Okada Y, Minakami H, Tomomasa T, et al. Serum procalcitonin concentration in patients with Kawasaki disease [ J ]. J Infect, 2004,48 (2) :199-205.

二级参考文献14

  • 1胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:688-690.
  • 2Baddour LM,Wilson WR,Bayer AS,et al.Infective endocarditis:Diagnosis,antimicrobial therapy,and management of complications:A statement for healthcare professionals from the Committee on Rheumatic Fever,Endocarditis,and Kawasaki Disease,Council on Cardiovascular Disease in the Young,and the Councils on Clinical Cardiology,Stroke,and Cardiovascular Surgery and Anesthesia,American Heart Association:Endorsed by the infectious disease society of America[J].Circulation,2005,111(23):394-434.
  • 3Falcini F.Kawasaki disease[J].Curr Opin Rheumatol,2006,18(1):33-38.
  • 4Sponholz C,Sakr Y,Reinhart K,et al.Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery:A systematic review of the literature[J].Crit Care,2006,10(5):R145.
  • 5Kafetzis DA,Tigani GS,Costalos C.Immunologic markers in the neonatal period:Diagnostic value and accuracy in infection[J].Expert Rev Mol Diagn,2005,5(2):231-239.
  • 6Lopez Sastre JB,Perez Solis D,Roques Serradilla V,et al.Procalcitonin is not sufficiently reliable to be the sole marker of neonatal sepsis of no-socomial origin[J].BMC Pediatr,2006,6:16.
  • 7Scire CA,Caporali R,Perotti C,et al.Plasma procalcitonin in rheuma-tic diseases[J].Reumatismo,2003,55(2):113-118.
  • 8Bartosz K,Agnieszka MJ,Andrzej P.High serum procalcitonin concentration in Kawasaki disease[J].Med Sci Monit,1998,4(6):1072-1074.
  • 9Yeyng RS.Pathogenesis and treatment of Kawasaki's disease[J].Curr Opin Rheumatol,2005,17(5):617-623.
  • 10Whang KT,Vath SD,Becker KL,et al.Procalcitonin and proinflammatory cytokine interactions in sepsis[J].Shock,2000,14(1):73-78.

共引文献1208

同被引文献16

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部